News
ASCO 2025 multimodal artificial intelligence (MMAI) model, androgen receptor pathway inhibitors (ARPI), high-risk non-metastatic prostate cancer, STAMPEDE. ASCO 2025: Multimodal Artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback